The ulcerative colitis drug market is experiencing significant growth, driven by increasing disease prevalence and advancements in therapeutic options. Market Growth Analysis Global ulcerative colitis drug market is expected to reach USD 12.98 billion by 2033, at a CAGR of 5% from 2024 to 2033. Global ulcerative colitis drug market is witnessing a considerable growth owing to...